Yang Ge1, Leonardo Martinez2, Shengzhi Sun3, Zhiping Chen4, Feng Zhang5, Fangyu Li6, Wanwan Sun4, Enfu Chen4, Jinren Pan4, Changwei Li7, Jimin Sun4, Andreas Handel1, Feng Ling4, Ye Shen1. 1. Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens. 2. Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts. 3. Department of Environmental Health, School of Public Health, Boston University, Boston, Massachusetts. 4. Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China. 5. Department of Biostatistics and Data Science, School of Public Health, University of Texas Health Science Center at Houston, Houston. 6. Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, University of Texas Health Science Center at Houston, Houston. 7. Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana.
Abstract
Importance: Much remains unknown about the transmission dynamics of COVID-19. How the severity of the index case and timing of exposure is associated with disease in close contacts of index patients with COVID-19 and clinical presentation in those developing disease is not well elucidated. Objectives: To investigate the association between the timing of exposure and development of disease among close contacts of index patients with COVID-19 and to evaluate whether the severity of the index case is associated with clinical presentation in close contacts who develop COVID-19. Design, Setting, and Participants: This study used a large, population-based cohort of 730 individuals (index patients) who received a diagnosis of COVID-19 in Zhejiang Province, China, from January 8 to July 30, 2020, along with a contact tracing surveillance program. Field workers visited 8852 close contacts of the index patients and evaluated them for COVID-19 through August 2020. A timeline was constructed to characterize different exposure periods between index patients and their contacts. Main Outcomes and Measures: The primary outcome was the attack rate of COVID-19, defined as the total number of new COVID-19 cases diagnosed among contacts of index patients divided by the total number of exposed contacts. A secondary outcome was asymptomatic clinical presentation among infected contacts. Relative risks were calculated to investigate risk factors for COVID-19 among contacts and asymptomatic clinical presentation among infected contacts. Results: Among 8852 close contacts (4679 male contacts [52.9%]; median age, 41 years [interquartile range, 28-54 years]) of 730 index patients (374 male patients [51.2%]; median age, 46 years [interquartile range, 36-56 years]), contacts were at highest risk of COVID-19 if they were exposed between 2 days before and 3 days after the index patient's symptom onset, peaking at day 0 (adjusted relative risk [ARR], 1.3; 95% CI, 1.2-1.5). Compared with being exposed to an asymptomatic index patient, the risk of COVID-19 among contacts was higher when they were exposed to index patients with mild (ARR, 4.0; 95% CI, 1.8-9.1) and moderate (ARR, 4.3; 95% CI, 1.9-9.7) cases of COVID-19. As index case severity increased, infected contacts were less likely to be asymptomatic (exposed to patient with mild COVID-19: ARR, 0.3; 95% CI, 0.1-0.9; exposed to patient with moderate COVID-19: ARR, 0.3; 95% CI, 0.1-0.8). Conclusions and Relevance: This cohort study found that individuals with COVID-19 were most infectious a few days before and after symptom onset. Infected contacts of asymptomatic index patients were less likely to present with COVID-19 symptoms, suggesting that quantity of exposure may be associated with clinical presentation in close contacts.
Importance: Much remains unknown about the transmission dynamics of COVID-19. How the severity of the index case and timing of exposure is associated with disease in close contacts of index patients with COVID-19 and clinical presentation in those developing disease is not well elucidated. Objectives: To investigate the association between the timing of exposure and development of disease among close contacts of index patients with COVID-19 and to evaluate whether the severity of the index case is associated with clinical presentation in close contacts who develop COVID-19. Design, Setting, and Participants: This study used a large, population-based cohort of 730 individuals (index patients) who received a diagnosis of COVID-19 in Zhejiang Province, China, from January 8 to July 30, 2020, along with a contact tracing surveillance program. Field workers visited 8852 close contacts of the index patients and evaluated them for COVID-19 through August 2020. A timeline was constructed to characterize different exposure periods between index patients and their contacts. Main Outcomes and Measures: The primary outcome was the attack rate of COVID-19, defined as the total number of new COVID-19 cases diagnosed among contacts of index patients divided by the total number of exposed contacts. A secondary outcome was asymptomatic clinical presentation among infected contacts. Relative risks were calculated to investigate risk factors for COVID-19 among contacts and asymptomatic clinical presentation among infected contacts. Results: Among 8852 close contacts (4679 male contacts [52.9%]; median age, 41 years [interquartile range, 28-54 years]) of 730 index patients (374 male patients [51.2%]; median age, 46 years [interquartile range, 36-56 years]), contacts were at highest risk of COVID-19 if they were exposed between 2 days before and 3 days after the index patient's symptom onset, peaking at day 0 (adjusted relative risk [ARR], 1.3; 95% CI, 1.2-1.5). Compared with being exposed to an asymptomatic index patient, the risk of COVID-19 among contacts was higher when they were exposed to index patients with mild (ARR, 4.0; 95% CI, 1.8-9.1) and moderate (ARR, 4.3; 95% CI, 1.9-9.7) cases of COVID-19. As index case severity increased, infected contacts were less likely to be asymptomatic (exposed to patient with mild COVID-19: ARR, 0.3; 95% CI, 0.1-0.9; exposed to patient with moderate COVID-19: ARR, 0.3; 95% CI, 0.1-0.8). Conclusions and Relevance: This cohort study found that individuals with COVID-19 were most infectious a few days before and after symptom onset. Infected contacts of asymptomatic index patients were less likely to present with COVID-19 symptoms, suggesting that quantity of exposure may be associated with clinical presentation in close contacts.
Authors: Elizabeth T Chin; Benjamin Q Huynh; Lloyd A C Chapman; Matthew Murrill; Sanjay Basu; Nathan C Lo Journal: Clin Infect Dis Date: 2021-11-02 Impact factor: 9.079
Authors: Antonio Gasparrini; Yuming Guo; Francesco Sera; Ana Maria Vicedo-Cabrera; Veronika Huber; Shilu Tong; Micheline de Sousa Zanotti Stagliorio Coelho; Paulo Hilario Nascimento Saldiva; Eric Lavigne; Patricia Matus Correa; Nicolas Valdes Ortega; Haidong Kan; Samuel Osorio; Jan Kyselý; Aleš Urban; Jouni J K Jaakkola; Niilo R I Ryti; Mathilde Pascal; Patrick G Goodman; Ariana Zeka; Paola Michelozzi; Matteo Scortichini; Masahiro Hashizume; Yasushi Honda; Magali Hurtado-Diaz; Julio Cesar Cruz; Xerxes Seposo; Ho Kim; Aurelio Tobias; Carmen Iñiguez; Bertil Forsberg; Daniel Oudin Åström; Martina S Ragettli; Yue Leon Guo; Chang-Fu Wu; Antonella Zanobetti; Joel Schwartz; Michelle L Bell; Tran Ngoc Dang; Dung Do Van; Clare Heaviside; Sotiris Vardoulakis; Shakoor Hajat; Andy Haines; Ben Armstrong Journal: Lancet Planet Health Date: 2017-12
Authors: Ashleigh Myall; James R Price; Robert L Peach; Mohamed Abbas; Sid Mookerjee; Nina Zhu; Isa Ahmad; Damien Ming; Farzan Ramzan; Daniel Teixeira; Christophe Graf; Andrea Y Weiße; Stephan Harbarth; Alison Holmes; Mauricio Barahona Journal: Lancet Digit Health Date: 2022-08
Authors: Rodrigo Alonso; Ana M Camon; Celia Cardozo; Laia Albiach; Daiana Agüero; M Angeles Marcos; Juan Ambrosioni; Marta Bodro; Mariana Chumbita; Lorena de la Mora; Nicole Garcia-Pouton; Gerard Dueñas; Marta Hernandez-Meneses; Alexy Inciarte; Genoveva Cuesta; Fernanda Meira; Laura Morata; Pedro Puerta-Alcalde; Sabina Herrera; Montse Tuset; Pedro Castro; Sergio Prieto-Gonzalez; Josep Mensa; José Antonio Martínez; Gemma Sanjuan; J M Nicolas; A Del Rio; Jordi Vila; Felipe Garcia; Carolina Garcia-Vidal; Alex Soriano Journal: Infect Dis Ther Date: 2022-04-27
Authors: Usha Stiefel; Davinder Bhullar; Trina F Zabarsky; Natalie F Palmieri; Kimberly D Diaz; Maria M Torres-Teran; Curtis J Donskey Journal: Infect Control Hosp Epidemiol Date: 2022-02-08 Impact factor: 3.254